Response of Clostridium Difficile Infection to Metronidazole Therapy

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

In this record review study, our objective is to determine the rates of cure, failure and relapse following treatment of C. difficile colitis with metronidazole.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Michael E. DeBakey VA Medical Center; VA Medical Center, Houston
• Collaborator: Baylor College of Medicine
• Treatments: Metronidazole

Criteria

Inclusion Criteria:

• records of patients who have a fecal sample positive for C. difficile toxin and who are then treated for C. difficile colitis with oral metronidazole will be included in this study.

Exclusion Criteria:

• Patients who did not receive at least 7 days of metronidazole